Authors
Loading...
Preclinical evaluation demonstrates potent D-amino acid oxidase inhibition and enhanced plasma D-serine levels in mice, indicating therapeutic potential as a metabolic pharmacoenhancer.
Hin et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: